EmployblEmploybl logo
employbl
TORL BioTherapeutics logo

TORL BioTherapeutics Funding & Investors

TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.

torlbio.com

Total Amount Raised: $316,000,000

TORL BioTherapeutics Funding Rounds

  • Series B

    $158,000,000

    Series B Investors

    Deep Track Capital
    Ra Capital Management
    Bristol-Myers Squibb
    Vertex Ventures HC
    Avidity Partners Management
    Blue Owl
    Moore Strategic Ventures
    Goldman Sachs
    UCOP
    Perceptive Advisors
    Xontogeny
    UC Investments
    Gianna Hoffman-Luca

  • Series B

    $158,000,000

    Series B Investors

    Goldman Sachs Asset Management
    Cowen
    Vertex Ventures HC
    Moore Strategic Ventures
    Bristol-Myers Squibb
    Alexandria Venture Investments
    Deep Track Capital
    OCV Management
    UC Investments
    Perceptive Advisors
    Vest Coast Capital
Funding info provided by Diffbot.